Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Positron emission mammography in the evaluation of interim response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Soldevilla-Gallardo I, Villaseñor-Navarro Y, Medina-Ornelas SS, Villarreal-Garza C, Bargalló-Rocha E, Caro-Sánchez CH, Gallardo-Alvarado LN, Hernández-Ramírez R, Arela-Quispe LM, García-Pérez FO. Soldevilla-Gallardo I, et al. Cancer Treat Res Commun. 2018;16:24-31. doi: 10.1016/j.ctarc.2018.05.001. Epub 2018 May 14. Cancer Treat Res Commun. 2018. PMID: 31298999
68Ga-DTPA Anti-HER2 positron emission tomography/CT successfully predicts the overexpression of human epidermal growth factor receptor in lung metastases from breast cancer.
Pitalúa-Cortés QG, García-Pérez FO, Villaseñor-Navarro Y, Lara-Medina FU, Matus-Santos JA, Soldevilla-Gallardo I, Porras-Reyes FI, Pérez-Sánchez VM, Maldonado-Martínez HA, Pérez-Báez W, Sollozo-Dupont I. Pitalúa-Cortés QG, et al. BJR Case Rep. 2017 May 6;3(3):20160136. doi: 10.1259/bjrcr.20160136. eCollection 2017. BJR Case Rep. 2017. PMID: 30363270 Free PMC article.
Head to head comparison performance of 99mTc-EDDA/HYNIC-iPSMA SPECT/CT and 68Ga-PSMA-11 PET/CT a prospective study in biochemical recurrence prostate cancer patients.
García-Pérez FO, Davanzo J, López-Buenrostro S, Santos-Cuevas C, Ferro-Flores G, Jímenez-Ríos MA, Scavuzzo A, Santana-Ríos Z, Medina-Ornelas S. García-Pérez FO, et al. Am J Nucl Med Mol Imaging. 2018 Oct 20;8(5):332-340. eCollection 2018. Am J Nucl Med Mol Imaging. 2018. PMID: 30510850 Free PMC article.
177Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer.
Santos-Cuevas C, Ferro-Flores G, García-Pérez FO, Jiménez-Mancilla N, Ramírez-Nava G, Ocampo-García B, Luna-Gutiérrez M, Azorín-Vega E, Davanzo J, Soldevilla-Gallardo I. Santos-Cuevas C, et al. Contrast Media Mol Imaging. 2018 Nov 11;2018:5247153. doi: 10.1155/2018/5247153. eCollection 2018. Contrast Media Mol Imaging. 2018. PMID: 30534027 Free PMC article.
Head-to-Head Comparison of 68Ga-PSMA-11 and 131I in the Follow-Up of Well-Differentiated Metastatic Thyroid Cancer: A New Potential Theragnostic Agent.
Pitalua-Cortes Q, García-Perez FO, Vargas-Ahumada J, Gonzalez-Rueda S, Gomez-Argumosa E, Ignacio-Alvarez E, Soldevilla-Gallardo I, Torres-Agredo L. Pitalua-Cortes Q, et al. Among authors: garcia perez fo. Front Endocrinol (Lausanne). 2021 Dec 22;12:794759. doi: 10.3389/fendo.2021.794759. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 35002972 Free PMC article.
Multitarget Molecular Imaging in Metastatic Castration Resistant Adenocarcinoma Prostate Cancer with Therapy Induced Neuroendocrine Differentiation.
Vargas Ahumada J, González Rueda SD, Sinisterra Solís FA, Pitalúa Cortés Q, Torres Agredo LP, Miguel JR, Scavuzzo A, Soldevilla-Gallardo I, Álvarez Avitia MA, Sobrevilla N, García Pérez FO. Vargas Ahumada J, et al. Among authors: garcia perez fo. Diagnostics (Basel). 2022 Jun 3;12(6):1387. doi: 10.3390/diagnostics12061387. Diagnostics (Basel). 2022. PMID: 35741197 Free PMC article.
27 results